Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05211180 · ClinicalTrials.gov registry record · NA
Vida Sana y Completa Obesity and Food Insecurity Study
A NA study of Obesity, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 412
- Enrollment target
- 1
- Study location
NCT05211180: Active NA study of Obesity, sponsored by Stanford University.
NCT05211180 is a NA study of Obesity that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 412 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05211180, a NA study of Obesity, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 412 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the Vida Sana y Completa study is to provide evidence on the most effective approach for addressing the critical combination of obesity and food insecurity among Latinas in primary care while also collecting preliminary information on the potential for implementation and dissemination.
Primary Outcome
Trained research assistants blinded to treatment assignment will weigh participants in duplicate using a standard calibrated scale at baseline, 12, and 24 months
Conditions Studied
Interventions
- BEHAVIORAL Vida Sana
- BEHAVIORAL Vida Sana y Completa
Study Locations (1)
California
- San Mateo Medical Center Fair Oaks Health Center - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 412 participants |
| Start Date | 2022-09-27 |
| Est. Completion | 2027-10 |
| Phase | NA |
What the registry record for NCT05211180 still lists
NCT05211180 is an interventional study that assigns participants to a tested intervention. The registered 412 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Vida Sana is the first listed.
NCT05211180 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05211180 about?
NCT05211180 is a clinical study titled "Vida Sana y Completa Obesity and Food Insecurity Study". The goal of the Vida Sana y Completa study is to provide evidence on the most effective approach for addressing the critical combination of obesity and food insecurity among Latinas in primary care while also collecting preliminary information on the potential for implementation and dissemination.
What is the current status of trial NCT05211180?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 412 participants. The study started on 2022-09-27. Estimated completion is 2027-10.
What conditions does trial NCT05211180 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT05211180?
The interventions under investigation include: Vida Sana (BEHAVIORAL), Vida Sana y Completa (BEHAVIORAL).
Who is sponsoring clinical trial NCT05211180?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05211180 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05211180's enrollment target sits among peer trials
412 165th of 1053 higher than 889 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05993689 · 412 participants · NA
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
- NCT06699212 · 412 participants · Phase 3
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI